Europe Histopathology Services Market to Rise $8,766 Million by 2023 End

According to a new report published by Allied Market Research, titled, Europe Histopathology Services Market by Type of Examination: Opportunity Analysis and Industry Forecast, 2017-2023,"the Europe histopathology services market was valued at $5,583 million in 2016, and is expected to reach $8,766 million by 2023, growing at a CAGR of 6.6% from 2017 to 2023.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/4103

Histopathology is a branch of pathology, which deals with the study of changes in tissue occurring due to a disease. In this procedure, suspected tissues (for a disease) are removed from a patient's body and examined in a laboratory to study manifestations of the disease.

Increase in prevalence of cancer & other chronic disorders, rapid growth in geriatric population in Europe, and rise in public awareness towards disease screening drive the growth of the Europe histopathology services market. However, limitations of histopathology, as the technique is subjected to human error during analysis and preparation of tissue slides, and dearth of pathologists & medical laboratory scientists in the UK are expected to impede the market growth. On the contrary, increase in demand for personalized medicine is expected to offer ample opportunities for market expansion during the forecast period.

The surgical specimen segment accounted for nearly half of the market share in 2016, and is expected to maintain its dominant position during the analysis period, owing to increase in number of surgical procedures across Europe.

Analyst Review

The adoption of histopathology services is expected to increase in the near future, owing to rise in prevalence of infectious diseases and cancer in the European region. Moreover, surge in demand for personalized medicine propels the market growth. The histopathology services market has gained traction among healthcare providers, as these tests help to diagnose a disease, stage or extent of a malignant disease, and identify the presence of unsuspected concurrent diseases. Moreover, these tests can be used to provide information for postoperative treatment in certain surgical procedures. In addition, rapid surge in geriatric population in Europe is anticipated to drive the market growth.

For More Details on this Report visit @ https://www.alliedmarketresearch.com/europe-histopathology-lab-market

Key Findings of the Europe Histopathology Services Market :

• The liver biopsy segment is expected to grow at a CAGR of 9.9% from 2017 to 2023.
• UK is expected to grow at the highest CAGR of 7.4%.
• Germany held a major share of 19.6% in 2016 in the European market, and is expected to retain its position throughout the forecast period.
• Gastrointestinal biopsy segment held a share of 11.6% in 2016.

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.